Broncus Holding Corporation
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, and internationally. The company offers InterVapor, a thermal vapor treatment system to treat chronic obstructive pulmonary disease (COPD); BroncAblate Radiofrequency Ablation System, a transbronchial interventional treatment product for l… Read more
Broncus Holding Corporation (BRNHF) - Total Liabilities
Latest total liabilities as of June 2025: $5.29 Million USD
Based on the latest financial reports, Broncus Holding Corporation (BRNHF) has total liabilities worth $5.29 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Broncus Holding Corporation - Total Liabilities Trend (2019–2024)
This chart illustrates how Broncus Holding Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Broncus Holding Corporation Competitors by Total Liabilities
The table below lists competitors of Broncus Holding Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NicOx S.A.
PA:ALCOX
|
France | €19.39 Million |
|
JMC Electronics Co Ltd
TW:6552
|
Taiwan | NT$1.25 Billion |
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
USA | $11.08 Million |
|
Sono-Tek Corp
NASDAQ:SOTK
|
USA | $4.80 Million |
|
Mahkota Group Tbk PT
JK:MGRO
|
Indonesia | Rp2.60 Trillion |
|
Saultech Technology Co., Ltd
TWO:6812
|
Taiwan | NT$350.21 Million |
|
Atlas Resources Tbk
JK:ARII
|
Indonesia | Rp509.35 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Broncus Holding Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 26.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Broncus Holding Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Broncus Holding Corporation (2019–2024)
The table below shows the annual total liabilities of Broncus Holding Corporation from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.42 Million | -38.50% |
| 2023-12-31 | $10.44 Million | +23.11% |
| 2022-12-31 | $8.48 Million | -18.38% |
| 2021-12-31 | $10.39 Million | -93.60% |
| 2020-12-31 | $162.32 Million | +69.29% |
| 2019-12-31 | $95.88 Million | -- |